Insight into the Anticancer Potential of Imidazole-Based Derivatives Targeting Receptor Tyrosine Kinases

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Kinases are essential signaling enzymes, regulating critical cellular processes, and their dysregulation is linked to diseases like cancer.
• Kinase inhibitors are crucial therapeutic targets, with imidazole and benzimidazole scaffolds offering versatile structures for drug development.
• Targeting specific tyrosine kinases such as FGFRs, c-Met, EGFRs, VEGFRs, and FLT3 is a key strategy in cancer treatment.

Purpose of the Study:

• To review the application of imidazole and benzimidazole frameworks in developing inhibitors against specific tyrosine kinases.
• To consolidate fundamental structural information for synthesizing effective imidazole- or benzimidazole-based tyrosine kinase inhibitors.

Main Methods:

• Literature review of imidazole and benzimidazole derivatives targeting specific tyrosine kinases from 2020 to present.
• Examination of major structure-activity correlations (SARs) for these derivatives.
• Inclusion of docking studies to analyze interactions within tyrosine protein kinase active sites.

Main Results:

• Identified key structural features of imidazole and benzimidazole derivatives influencing inhibitory activity against target kinases.
• Detailed SARs provide insights into optimizing inhibitor design for enhanced potency and selectivity.
• Docking studies reveal specific binding interactions, aiding in the rational design of novel kinase inhibitors.

Conclusions:

• Imidazole and benzimidazole scaffolds are highly effective in designing potent and selective tyrosine kinase inhibitors.
• Understanding SARs and molecular interactions is vital for developing next-generation kinase-targeted cancer therapies.
• This review provides a foundational resource for medicinal chemists synthesizing novel inhibitors for various tyrosine kinases.